---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-016201"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:36:31.307688+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Cumberland Pharmaceuticals announces retirement of EVP Leo Pavliv

## Summary
- Leo Pavliv retired as EVP, Chief Development & Operations Officer effective May 31, 2022.
- Pavliv entered into a consulting agreement to remain as Operations Advisor to the company.
- His regulatory, product development and manufacturing duties have been assigned to other executives.

## SEC filing metadata
- accession: 0001628280-22-016201
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/0001628280-22-016201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/cpix-20220603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-016201
- JSON: https://secwatch.observer/filing/0001628280-22-016201.json
- Plain text: https://secwatch.observer/filing/0001628280-22-016201.txt

## Key facts
- Executive change
  Leo Pavliv retired as Executive Vice President, Chief Development & Operations Officer at CUMBERLAND PHARMACEUTICALS INC.
  - Action: retired
  - Role: Executive Vice President, Chief Development & Operations Officer
  source text: On May 31, 2022, Cumberland Pharmaceuticals Inc. ("Cumberland" or the "Company") announced the retirement of Leo Pavliv, Cumberland’s Executive Vice President, Chief Development & Operations Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/0001628280-22-016201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.